Biography

Claus Crone Fuglsang
Education:
Cand. scient Biochemistry, University of Copenhagen 1988-1993;
MBA, Heriot-Watt University, Edinburgh Business School, UK 1996-2000;
Completed various management and leadership courses at MIT, Boston and IMD, Lausanne
Novonesis (Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd) is the worlds largest Biosolutions Company – Biosolutions in the form of enzymes, cultures, yeast and probiotics for use in industrial, agricultural, animal husbandry, food processing, food products and dietary supplements
Responsible for Novonesis global R&D organization with around 2000 employes and an annual budget of +400 MEUR. covering the basic research disciplines as well as the business anchored Applied Research.
Covering a broad area of research disciplines within advanced biotechnology research from discovery to development and scale up in pilot plants as well as regulatory affairs and product safety alongside our Intellectual Property and licensing activities as well as wide range of industry specific application research. Also, overseeing the data and digital innovation strategy incl. application of machine learning to drive innovation.
Author/co-author of 30+ publications and inventor/co-inventor on more than 20 patents and patent-applications.
Board Memberships:
Member of the Board of Directors in Microbiogen Ltd. Australia
Member of the Board of Directors 21st Bio, Denmark
Advisory Board Faculty of Bioengineering, Danish Technical University
Vice Chair of the ATV Guide committee
